NextPlat Reports Q3 2026 Results with Improved Gross Margins and Reduced Operating Losses

NextPlat (NXPL) reported third-quarter 2026 financial results characterized by a strategic shift toward higher-margin contracted services. While total net revenue declined to $10.5 million from $13.8 million in the prior year due to operational restructuring and changing healthcare reimbursement dynamics, the company successfully expanded its consolidated gross margin to 35%, up from approximately 20% in the previous year. The company significantly improved its bottom line, reducing its operating loss by 65% to $0.8 million compared to the prior year's $2.2 million loss. This improvement was driven by disciplined cost controls and a surge in contracted pharmacy revenue, which grew fourfold to $2.4 million. Despite headwinds in total prescription volume and reimbursement rates, NextPlat's focus on high-margin 340B contracts and e-commerce stability provides a foundation for improved profitability.

5 articles from 2 sources · updated

Coverage